151 related articles for article (PubMed ID: 8063042)
41. Muscle insulin resistance in uremic humans: glucose transport, glucose transporters, and insulin receptors.
Friedman JE; Dohm GL; Elton CW; Rovira A; Chen JJ; Leggett-Frazier N; Atkinson SM; Thomas FT; Long SD; Caro JF
Am J Physiol; 1991 Jul; 261(1 Pt 1):E87-94. PubMed ID: 1858877
[TBL] [Abstract][Full Text] [Related]
42. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training.
Dela F; Larsen JJ; Mikines KJ; Ploug T; Petersen LN; Galbo H
Diabetes; 1995 Sep; 44(9):1010-20. PubMed ID: 7657022
[TBL] [Abstract][Full Text] [Related]
43. Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients.
Vestergaard H; Bjørbaek C; Andersen PH; Bak JF; Pedersen O
Diabetes; 1991 Dec; 40(12):1740-5. PubMed ID: 1756915
[TBL] [Abstract][Full Text] [Related]
44. Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients.
Henriksen JE; Alford F; Ward GM; Beck-Nielsen H
Diabetologia; 1997 Dec; 40(12):1439-48. PubMed ID: 9447952
[TBL] [Abstract][Full Text] [Related]
45. High fat feeding causes insulin resistance and a marked decrease in the expression of glucose transporters (Glut 4) in fat cells of rats.
Pedersen O; Kahn CR; Flier JS; Kahn BB
Endocrinology; 1991 Aug; 129(2):771-7. PubMed ID: 1855475
[TBL] [Abstract][Full Text] [Related]
46. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
[TBL] [Abstract][Full Text] [Related]
47. Troglitazone regulation of glucose metabolism in human skeletal muscle cultures from obese type II diabetic subjects.
Park KS; Ciaraldi TP; Abrams-Carter L; Mudaliar S; Nikoulina SE; Henry RR
J Clin Endocrinol Metab; 1998 May; 83(5):1636-43. PubMed ID: 9589670
[TBL] [Abstract][Full Text] [Related]
48. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
[TBL] [Abstract][Full Text] [Related]
49. Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM.
Widén EI; Eriksson JG; Groop LC
Diabetes; 1992 Mar; 41(3):354-8. PubMed ID: 1551495
[TBL] [Abstract][Full Text] [Related]
50. Glucose uptake and GLUT-4 protein distribution in skeletal muscle of the obese Zucker rat.
Brozinick JT; Etgen GJ; Yaspelkis BB; Ivy JL
Am J Physiol; 1994 Jul; 267(1 Pt 2):R236-43. PubMed ID: 8048627
[TBL] [Abstract][Full Text] [Related]
51. Decreased expression of glucose transporter in muscle from insulin-resistant patients.
Dohm GL; Elton CW; Friedman JE; Pilch PF; Pories WJ; Atkinson SM; Caro JF
Am J Physiol; 1991 Mar; 260(3 Pt 1):E459-63. PubMed ID: 2003599
[TBL] [Abstract][Full Text] [Related]
52. Increased insulin-stimulated glucose uptake in athletes: the importance of GLUT4 mRNA, GLUT4 protein and fibre type composition of skeletal muscle.
Andersen PH; Lund S; Schmitz O; Junker S; Kahn BB; Pedersen O
Acta Physiol Scand; 1993 Dec; 149(4):393-404. PubMed ID: 8128887
[TBL] [Abstract][Full Text] [Related]
53. Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon?
Eriksson JW; Smith U; Waagstein F; Wysocki M; Jansson PA
Diabetes; 1999 Aug; 48(8):1572-8. PubMed ID: 10426375
[TBL] [Abstract][Full Text] [Related]
54. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM.
Laakso M; Edelman SV; Brechtel G; Baron AD
Diabetes; 1992 Sep; 41(9):1076-83. PubMed ID: 1499861
[TBL] [Abstract][Full Text] [Related]
55. Regulation of hexokinase II and glycogen synthase mRNA, protein, and activity in human muscle.
Mandarino LJ; Printz RL; Cusi KA; Kinchington P; O'Doherty RM; Osawa H; Sewell C; Consoli A; Granner DK; DeFronzo RA
Am J Physiol; 1995 Oct; 269(4 Pt 1):E701-8. PubMed ID: 7485484
[TBL] [Abstract][Full Text] [Related]
56. Differential expression of rat pancreatic islet beta-cell glucose transporter (GLUT 2), proinsulin and islet amyloid polypeptide genes after prolonged fasting, insulin-induced hypoglycaemia and dexamethasone treatment.
Koranyi L; Bourey R; Turk J; Mueckler M; Permutt MA
Diabetologia; 1992 Dec; 35(12):1125-32. PubMed ID: 1282477
[TBL] [Abstract][Full Text] [Related]
57. Normalization of insulin secretion by a selective alpha 2-adrenoceptor antagonist restores GLUT-4 glucose transporter expression in adipose tissue of type II diabetic rats.
Angel I; Burcelin R; Prouteau M; Girard J; Langer SZ
Endocrinology; 1996 May; 137(5):2022-7. PubMed ID: 8612543
[TBL] [Abstract][Full Text] [Related]
58. Time courses of changes in hepatic and skeletal muscle insulin action and GLUT4 protein in skeletal muscle after STZ injection.
Youn JH; Kim JK; Buchanan TA
Diabetes; 1994 Apr; 43(4):564-71. PubMed ID: 8138062
[TBL] [Abstract][Full Text] [Related]
59. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
Bitar MS; Al-Saleh E; Al-Mulla F
Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
[TBL] [Abstract][Full Text] [Related]
60. Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus.
Kusari J; Verma US; Buse JB; Henry RR; Olefsky JM
J Clin Invest; 1991 Oct; 88(4):1323-30. PubMed ID: 1918382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
